Dear eVIVA readers,

I’ve returned from the VIVA Physicians Board of Directors meeting, where the discussion focused on how to continue providing the best educational experience in the field of Vascular Medicine and Intervention. First, I'm delighted to share that The VEINS meeting will be back in Las Vegas to help us kick off VIVA 16. Next, we are well underway with planning for VIVA 16 with even more world-renowned faculty, live cases and late-breaking trials than ever before.

Based on attendee and faculty feedback, we will be offering:

An Opportunity for U.S. physicians-in-training to participate in the VIVA Face-Off Competition and receive FREE registration to the VIVA Fellows Program
Increased Live Case interaction with physicians from all over the world
Extended Hands-On sessions with more topics to include Atherectomy, Thrombectory, Strokes and Filters
Exhibit opportunities available for The VEINS and VIVA Focus sessions (CLI and Aortic Armageddon) on Saturday and Sunday
International Physicians the opportunity to attend VIVA 16 online, using their own device, through Virtual VIVA and More!

For more information, visit www.vivaphysicians.org to stay up-to-date. As always, thank you for being part of the VIVA Physicians family and we hope you consider forwarding eVIVA to your colleagues and friends.

Best wishes,
John Kaufman
President, VIVA Physicians

VIVA@LINC Recap

In January, members of the VIVA Board of Directors presented a number of complex cases and hot topics at LINC 2016 in Leipzig, Germany. Watch The VEINS Course Director, Raghu Kolluri, MD, The VEINS Course Director and VIVA Board Member, Michael R. Jaff, DO and VIVA Board Member, Sean Lyden, MD present in the Discussion Forum.

MARK YOUR CALENDAR

Mid-March: Registration Opens
Sept. 17-18: The VEINS
Sept. 18-22: VIVA 16

VIVA Spotlight: Insights from the VIVA SFA Nitinol Stent Patient Level Meta-Analysis

Much more than a meeting, VIVA Physicians promotes research that encourages collaboration and ultimately delivers data to inform optimal patient care. At VIVA 15, Krishna Rocha-Singh, MD, reported on the impact of the performance goal established by VIVA Physicians in 2007 that has become the standard by which all subsequent nitinol stents placed in the SFA are assessed. Endorsed by the FDA and welcomed by industry, the “VIVA comparator” has provided six adjudicated patient-level data sets totaling 999 claudicants.

Watch as Dr. Rocha-Singh presents emerging insights from the SFA Nitinol Stent Patient Level Meta-Analysis, reviews the impact of this VIVA Physicians research initiative and announces the launch of the REALITY study.

VIVA Spotlight: The Roundtable - Transition from Warfarin to TSOAC to LMWH to UFH: Clarity Around the Madness

The VIVA 15 Roundtable delivered rapid-fire debate about the hottest topics in vascular medicine and intervention. View Ido Weinberg's, MD, presentation from VIVA as he drills down to the rules of thumb for anticoagulant transitions in venous management.

Stay Connected

VIVA Physicians is advancing vascular medicine and intervention 365 days a year. Share news about our educational, research, innovation and advocacy activities by following and connecting with us.

VIVA Physicians is A Not-For-Profit Organization Dedicated To Vascular Education And Research

VIVA Physicians Inc.
5671 Santa Teresa Blvd, Suite 104 San Jose, CA 95123
© VIVA Physicians Inc. 2015 All rights reserved.

You have received this message because you have subscribed to VIVA's email service.
unsubscribe from this list update subscription preferences